Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen—a Possible Novel Therapeutic Target-Reference-Cited by-同舟云学术

Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen—a Possible Novel Therapeutic Target

Published:2017-08-26 Issue:4 Volume:28 Page:339-344
ISSN:1046-3976
Container-title:Endocrine Pathology
language:en
Short-container-title:Endocr Pathol

Author:

Moore Maureen,Panjwani Suraj,Mathew Rashmi,Crowley Michael,Liu Yi-Fang,Aronova Anna,Finnerty Brendan,Zarnegar Rasa,Fahey Thomas J.,Scognamiglio Theresa

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Pathology and Forensic Medicine

Link

http://link.springer.com/article/10.1007/s12022-017-9500-9/fulltext.html

Reference23 articles.

1. Horn-Ross PL, Lichtensztajn DY, Clarke CA, Dosiou C, Oakley-Girvan I, Reynolds P, Gomez SL, Nelson DO. Continued rapid increase in thyroid cancer incidence in california: trends by patient, tumor, and neighborhood characteristics. Cancer Epidemiol Biomarkers Prev 2014; 23, 1067–1079.

2. Tuttle RM, Haddad RI, Ball DW, Byrd D, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, Lydiatt WM, McCaffrey J, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ, Hoffmann KG, Hughes M. Thyroid carcinoma, version 2.2014 J Natl Compr Canc Netw 2014; 12, 1671–1680; quiz 1680.

3. Antonelli A, Fallahi P, Ferrari SM, Carpi A, Berti P, Materazzi G, Minuto M, Guastalli M, Miccoli P. Dedifferentiated thyroid cancer: a therapeutic challenge. Biomed Pharmacother 2008; 62, 559–563.

4. Hughes DT, Laird AM, Miller BS, Gauger PG, Doherty GM. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin. Ann Surg Oncol 2012; 19, 2951–2957.

5. Ito Y, Suzuki S, Ito KI, Imai T, Okamoto T, Kitano H, Sugitani I, Sugino K, Tsutsui H, Hara H, Yoshida A, Shimizu K. Tyrosine-kinase inhibitors to treat radioiodine-refracted, metastatic, or recurred and progressive differentiated thyroid carcinoma [Review]. Endocr J 2016; 63, 597-602.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential application of [18F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma;EJNMMI Research;2024-09-12

2. Match Point: Nuclear Medicine Imaging for Recurrent Thyroid Cancer in TENIS Syndrome—Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2024-09-10

3. Intrahepatic cholangiocarcinoma detected on 18F-PSMA-1007 PET/MR imaging in a prostate cancer patient: a case report and literature review;Frontiers in Oncology;2024-06-12

4. Assessing Krenning’s score on 68Ga-DOTATATE PET-CT and miPSMA score on 68Ga-PSMA-11 PET-CT in TENIS: a comparison with FDG PET/CT and examining the feasibility of targeted radionuclide therapy;Nuclear Medicine Communications;2024-06-03

5. Retrospective analysis of thyroid incidentalomas detected by [68Ga]Ga-PSMA-11 PET/CT;Endocrine;2024-05-10